Metraipolis › archive › dc_7c35e33f389e

Repurposing primaquine diphosphate for imatinib-resistant chronic myeloid leukemia via targeting BCR-ABL and Wnt/β-catenin pathway — Europe PMC PMID:42403636

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42403636
DOI
10.1016/j.isci.2026.116415
License (as archived)
solo-consultazione
Archived
2026-10-18T14:46:58.869Z
SHA-256 of the archived text
d7c2d5de1eb3c0384308720cbf1fbacdf2c1283c0b7d54397bea447921151e12
Stable URL of this page
https://metraipolis.com/documento/dc_7c35e33f389e

How to cite

Repurposing primaquine diphosphate for imatinib-resistant chronic myeloid leukemia via targeting BCR-ABL and Wnt/β-catenin pathway — Europe PMC PMID:42403636 — Europe PMC (en), https://europepmc.org/article/MED/42403636 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7c35e33f389e (Metraipolis archive dc_7c35e33f389e, sha256 d7c2d5de1eb3c0384308720cbf1fbacdf2c1283c0b7d54397bea447921151e12)
BibTeX
@misc{dc7c35e33f389e,
  title = {Repurposing primaquine diphosphate for imatinib-resistant chronic myeloid leukemia via targeting BCR-ABL and Wnt/β-catenin pathway — Europe PMC PMID:42403636},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42403636},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7c35e33f389e; sha256 d7c2d5de1eb3c0384308720cbf1fbacdf2c1283c0b7d54397bea447921151e12},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42403636. Agents can read the archived copy with the MCP tool read_document.